Dutasteride is the chemical name in Avodart brand name manufactured by GlaxoSmithKline.
It inhibits the conversion of testosterone into dihydrotestosterone (DHT), DHT is involved in the development of benign prostatic hyperplasia (BPH).
Avodart is used to treat benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Dutasteride helps improve urinary flow and may also reduce your need for prostate surgery later on.
It is approved by the Food and Drug Administration (FDA) in the United States for the treatment of benign prostatic hyperplasia (BPH) and is prescribed off-label for the treatment of male pattern baldness (MPB).
Before taking Avodart, tell your doctor if you have ever had an allergic reaction to this medication, or to a similar medicine called finasteride (Propecia, Proscar).
Avodart is not recommended for women or a children,Do not donate blood while taking Avodart and for at least 6 months after your treatment ends. Avodart can be carried in the blood and could cause birth defects if a pregnant women receives a transfusion with blood that contains dutasteride.